{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:51:22Z","timestamp":1782449482291,"version":"3.54.5"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Perforating dermatoses comprise a heterogeneous group of skin disorders characterized by transepidermal elimination of dermal components such as collagen, elastic fibers, or fibrin, resulting in pruritic papulonodular lesions. Four established subtypes are identified: reactive perforating collagenosis (RPC), elastosis perforans serpiginosa, perforating folliculitis, and Kyrle disease. RPC can be hereditary, manifesting in childhood, or acquired (ARPC), which generally develops in maturity and is closely associated with systemic diseases, particularly chronic renal failure and diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 55-year-old male who presented with symptoms of decompensated heart failure, type-2 diabetes, chronic renal failure, and hyperparathyroidism. During hospitalization, he complained of cutaneous pruritus and skin lesions all over his body. Physical examination revealed papules of varying sizes; some progressed into umbilicated nodules featuring central keratotic plugs. Histopathology revealed cup-shaped epidermal invaginations with necrotic debris and transepidermal extrusion of modified collagen, as confirmed by Masson's trichrome stain (MTS). Therefore, a diagnosis of ARPC was established for the first time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention and outcome<\/jats:title>\n                    <jats:p>The patient was treated with the Dermovate scalp application, S.C. omalizumab administered monthly, fexofenadine hydrochloride, and body moisturizers. Besides that, treatment for glucose control, fluid overload, and recovery of renal function was also applied. Following up after 1 month revealed minimal improvement in pruritus; however, there was no change in skin lesion status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Acquired reactive perforating collagenosis remains a rare dermatologic disease. To the best of our knowledge, this represents the first reported case from Palestine. This case highlights the potential coexistence of ARPC with various systemic comorbidities, underscoring the need for comprehensive clinical assessment and exploration of underlying diseases in affected individuals. Furthermore, it highlights the importance of increased clinical awareness, particularly among physicians in similar settings, to consider ARPC in the differential diagnosis of pruritic cutaneous eruptions, especially in patients with associated comorbidities such as diabetes mellitus and chronic kidney disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1870746","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:37:44Z","timestamp":1782448664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acquired reactive perforating collagenosis in a patient with multiple comorbidities: a case report from Palestine"],"prefix":"10.3389","volume":"13","author":[{"given":"Majd","family":"Mohsen","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Al-Quds University","place":["Jerusalem, Palestine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Jaber","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Al-Quds University","place":["Jerusalem, Palestine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qais","family":"Naserallah","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Al-Maqassed Islamic Charitable Society Hospital","place":["Jerusalem, Palestine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montaser","family":"Badran","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Al-Maqassed Islamic Charitable Society Hospital","place":["Jerusalem, Palestine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Mtour","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Al-Maqassed Islamic Charitable Society Hospital","place":["Jerusalem, Palestine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Bannoura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Al-Makassed Islamic Charitable Society Hospital","place":["Jerusalem, Palestine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabee","family":"Adwan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Al-Quds University","place":["Jerusalem, Palestine"]},{"name":"Department of Infectious Diseases, Al-Makassed Islamic Charitable Society Hospital","place":["Jerusalem, Palestine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/archderm.1967.01610030055009","article-title":"Reactive perforating collagenosis","volume":"96","author":"Mehregan","year":"1967","journal-title":"Arch Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/jcm15010391","article-title":"Acquired reactive perforating collagenosis-a rare entity occurring within common disorders: a systematic review and our personal experience","volume":"15","author":"Junghetu","year":"2026","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0190-9622(94)70065-6","article-title":"Acquired reactive perforating collagenosis. Report of six cases and review of the literature","volume":"30","author":"Faver","year":"1994","journal-title":"J Am Acad Dermatol."},{"key":"B4","article-title":"Reactive perforating collagenosis","volume-title":"StatPearls","author":"Mullins","year":"2024"},{"key":"B5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1346-8138.2010.00918.x","article-title":"Acquired reactive perforating collagenosis: current status","volume":"37","author":"Karpouzis","year":"2010","journal-title":"J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/idoj.idoj_373_22","article-title":"Acquired reactive perforating collagenosis: case series","volume":"14","author":"Kollipara","year":"2022","journal-title":"Indian Dermatol Online J"},{"key":"B7","article-title":"Acquired perforating dermatosis","volume-title":"StatPearls","author":"Harbaoui","year":"2023"},{"key":"B8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1468-3083.2006.02085.x","article-title":"Familial reactive perforating collagenosis: a clinical, histopathological study of 10 cases","volume":"21","author":"Ramesh","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/archderm.1989.01670200050007","article-title":"Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers","volume":"125","author":"Rapini","year":"1989","journal-title":"Arch Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1468-3083.2006.01571.x","article-title":"Acquired perforating dermatosis: clinicopathological features in twenty-two cases","volume":"20","author":"Saray","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1590\/S0365-05962013000100012","article-title":"Allopurinol in the treatment of acquired reactive perforating collagenosis","volume":"88","author":"Tilz","year":"2013","journal-title":"An Bras Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3892\/etm.2020.8651","article-title":"Clinical characteristics and prognosis of acquired perforating dermatosis: a case report","volume":"19","author":"Wang","year":"2020","journal-title":"Exp Ther Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.21037\/acr-23-9","article-title":"Acquired perforating dermatosis in patients on peritoneal dialysis: a report of 3 cases","volume":"7","author":"Viejo-Boyano","year":"2023","journal-title":"AME Case Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2340\/0001555580384385","article-title":"Acquired reactive perforating collagenosis triggered by scabies infection","volume":"80","author":"Kurschat","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e4305","DOI":"10.1097\/MD.0000000000004305","article-title":"Acquired reactive perforating collagenosis: A report of a typical case","volume":"95","author":"Fei","year":"2016","journal-title":"Medicine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1684\/ejd.2013.2237","article-title":"Clinicopathological features of 25 patients with acquired perforating dermatosis","volume":"23","author":"Akoglu","year":"2013","journal-title":"Eur J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1365-2133.1999.02722.x","article-title":"Acquired reactive perforating collagenosis associated with diabetes mellitus: eight cases that meet Faver's criteria","volume":"140","author":"Kawakami","year":"1999","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3346\/jkms.2004.19.2.283","article-title":"Acquired perforating dermatosis in patients with chronic renal failure and diabetes mellitus","volume":"19","author":"Hong","year":"2004","journal-title":"J Korean Med Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5021\/ad.2014.26.2.162","article-title":"A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea","volume":"26","author":"Kim","year":"2014","journal-title":"Ann Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/jid.2009.269","article-title":"AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: Epidermal-dermal interaction in acquired perforating dermatosis","volume":"130","author":"Fujimoto","year":"2010","journal-title":"J Investig Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"adv40950","DOI":"10.2340\/actadv.v104.40950","article-title":"Ultra-high potency topical corticosteroids as a potential trigger for reactive perforating collagenosis","volume":"104","author":"Madanchi","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","article-title":"Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts","volume":"419","author":"Thornalley","year":"2003","journal-title":"Arch Biochem Biophys."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1870746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:37:54Z","timestamp":1782448674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1870746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1870746"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1870746","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1870746"}}